Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity. Issue 2 (19th September 2022)

Record Type:: Journal Article
Title:: Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity. Issue 2 (19th September 2022)
Main Title:: Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
Authors:: Calabrese, Cassandra
Kirchner, Elizabeth
Villa-Forte, Alexandra
Hajj-Ali, Rula A
Moss, Brandon P
Fernandez, James P
Calabrese, Leonard
Abstract:
Is Part Of:: RMD open. Volume 8:Issue 2(2022)
Journal:: RMD open
Issue:: Volume 8:Issue 2(2022)
Issue Display:: Volume 8, Issue 2 (2022)
Year:: 2022
Volume:: 8
Issue:: 2
Issue Sort Value:: 2022-0008-0002-0000
Page Start:
Page End:
Publication Date:: 2022-09-19
Subjects:: Antirheumatic Agents -- B-Lymphocytes -- COVID-19 -- Therapeutics
Musculoskeletal system -- Diseases -- Periodicals
Rheumatism -- Periodicals
616.7005
Journal URLs:: http://www.bmj.com/archive ↗
http://rmdopen.bmj.com/ ↗
DOI:: 10.1136/rmdopen-2022-002557 ↗
Languages:: English
ISSNs:: 2056-5933
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24023.xml